Anne Davidson
Hofstra University
3 Papers
7 Citations
Anne Davidson is an academic researcher from Hofstra University. The author has contributed to research in topics: Odds ratio & Retrospective cohort study. The author has an hindex of 2, co-authored 3 publications. Previous affiliations of Anne Davidson include The Feinstein Institute for Medical Research.
Chat about Author
Papers
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.
Dimitrios Giannis,Dimitrios Giannis,Steven L. Allen,James Tsang,Sarah Flint,Sarah Flint,Tamir Pinhasov,Tamir Pinhasov,Stephanie Williams,Stephanie Williams,Gary Tan,Gary Tan,Richa Thakur,Richa Thakur,Christian Leung,Christian Leung,Matthew Snyder,Matthew Snyder,Chirag Bhatia,Chirag Bhatia,David Garrett,David Garrett,Christina Cotte,Christina Cotte,Shelby Isaacs,Shelby Isaacs,Emma Gugerty,Emma Gugerty,Anne Davidson,Anne Davidson,Galina Marder,Austin Schnitzer,Bradley Goldberg,Thomas McGinn,Thomas McGinn,Karina W. Davidson,Karina W. Davidson,Matthew A. Barish,Michael Qiu,Meng Zhang,Mark Goldin,Mark Goldin,Miltiadis Matsagkas,Eleni Arnaoutoglou,Alex C. Spyropoulos,Alex C. Spyropoulos +45 more
TL;DR: In this paper, a prospective registry included consecutive patients with COVID-19 hospitalized within a multihospital system from 1 March to 31 May 2020, and the authors captured demographics, comorbidities, laboratory parameters, medications, postdischarge thromboprophylaxis, and 90-day outcomes.
169
Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry
Dimitrios Giannis,Steven L. Allen,Anne Davidson,Anne Davidson,Galina Marder,Sarah Flint,Sarah Flint,David Garrett,David Garrett,Richa Thakur,Richa Thakur,Matthew Snyder,Matthew Snyder,Cristina Ghiuzeli,Thomas McGinn,Thomas McGinn,Karina W. Davidson,Karina W. Davidson,Michael Qiu,Matthew A. Barish,Alex C. Spyropoulos,Alex C. Spyropoulos +21 more
TL;DR: An ongoing prospective registry consisting of 11,249 consecutive hospitalized patients with COVID-19 from March 1st 2020 through May 31st 2020 is designed and implemented to study through 90-days post-discharge the rate of VTE and ATE, major bleeding, all-cause mortality, and other complications.
11
Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients
Weiqing Huang,Tam D. Quach,Cosmin Dascalu,Zheng Liu,Tungming Leung,Miranda Byrne-Steele,Wenjing Pan,Qunying Yang,Jian Han,Martin Lesser,Thomas L. Rothstein,Richard Furie,Meggan Mackay,Cynthia Aranow,Anne Davidson +14 more
TL;DR: It is found that B cell-activating factor regulates the transitional B cell checkpoint, with conservation of transitional 1 (T1) cells and approximately 90% loss of T3 and naive B cells after chronic belimumab treatment.